Posted by AGORACOM-JC
at 8:45 AM on Wednesday, April 19th, 2017
Announced plans today for the joint distribution of dried medical cannabis in the maritime provinces and Quebec
Enter into a joint supply agreement, with Aphria supplying dried medical cannabis under its ACMPR license, and Tetra packaging the product using the manufacturing process developed for its in-progress clinical drug trial for PPP001
OTTAWA, ONTARIO–(April 19, 2017) –Tetra Bio-Pharma Inc. (“Tetra”) (CSE:TBP)(CSE:TBP.CN)(OTCQB:GRPOF) and Aphria Inc. (“Aphria”) (TSX:APH) (OTCQB:APHQF), announced plans today for the joint distribution of dried medical cannabis in the maritime provinces and Quebec.
Tetra and Aphria will enter into a joint supply agreement, with Aphria supplying dried medical cannabis under its ACMPR license, and Tetra packaging the product using the manufacturing process developed for its in-progress clinical drug trial for PPP001. The formulation and packaging will be completed by Tetra, under its CDSA dealer’s licence, at its New Brunswick facility. Based on the success of the venture, Tetra and Aphria may expand into other provinces. The venture is preparing to initiate its commercial operations early summer 2017 with revenues commencing in Tetra’s third quarter of 2017 and Aphria’s first quarter of 2018.
“This commercial venture is an important decision for Tetra shareholders as it will start generating revenues this summer which will be invested back into developing PPP001 as a prescription pharmaceutical,” said Andre Rancourt, CEO of Tetra Bio-Pharma Inc. “Tetra will be accelerating its manufacturing and quality studies as required by the U.S. and Canadian prescription drug and controlled substance regulations. The investment in this research will be offset by sales revenues generated under the ACMPR.”
“The commercial venture between Tetra and Aphria will enhance Aphria’s brand visibility and distribution of our high-quality medical grade cannabis into the maritime provinces and Quebec, as we look to meet the commercial demand for PPP001,” said Vic Neufeld, CEO of Aphria Inc. “As a leading Canadian licensed producer, it was important for us to work with an organization that shares our focus on pharmaceutical-grade quality assurance and control. Tetra’s emphasis on developing products driven by patient needs and scientific research and development makes them the perfect partner in this important next step for Aphria.”
Tetra and Aphria have invested in the development of its PPP001 drug and will continue to invest to bring PPP001 to market in both Canada and USA as the first prescription drug using dried cannabis. The corporations have developed a high quality dried cannabis product and would like to make it available to physicians under the current ACMPR program. The quality and clinical research studies completed to date would be integrated into a joint Continuing Medical Education program for physicians and pharmacists. Tetra and Aphria have concluded that there is demand for an evidence-based approach in medical cannabis and the two companies intend on using their pharmaceutical approach to help patients. The venture will also be commercializing devices for the inhalation of medical cannabis.
Tetra Bio-Pharma is a multi subsidiary publicly traded company (CSE:TBP)(CSE:TBP.CN)(OTCQB:GRPOF) engaged in the development of Bio Pharmaceuticals and Natural Health Products containing Cannabis and other medicinal plant based elements.
Tetra Bio-Pharma is focused on combining the traditional methods of medicinal cannabis use with the supporting scientific validation and safety data required for inclusion into the existing bio pharma industry by regulators physicians and insurance companies. More information is available about the company at: www.tetrabiopharma.com.
About Aphria:
Aphria Inc., one of Canada’s lowest cost producers, produces, supplies and sells medical cannabis. Located in Leamington, Ontario, the greenhouse capital of Canada. Aphria is truly powered by sunlight, allowing for the most natural growing conditions available. We are committed to providing pharma-grade medical cannabis, superior patient care while balancing patient economics and returns to shareholders. We are the first public licenced producer to report positive cash flow from operations and the first to report positive earnings in consecutive quarters. For more information, visit www.Aphria.com.
The Canadian Securities Exchange (“CSE”) has not reviewed this news release and does not accept responsibility for its adequacy or accuracy.
Forward-looking statements – Tetra Bio-Pharma Inc.
Some statements in this release may contain forward-looking information. All statements, other than of historical fact, that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future (including, without limitation, statements regarding potential acquisitions and financings) are forward-looking statements. Forward-looking statements are generally identifiable by use of the words “may”, “will”, “should”, “continue”, “expect”, “anticipate”, “estimate”, “believe”, “intend”, “plan” or “project” or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Company’s ability to control or predict, that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements. Factors that could cause actual results or events to differ materially from current expectations include, among other things, without limitation, the inability of the Company, through its wholly-owned subsidiary, GrowPros MMP Inc., to obtain a licence for the production of medical marijuana; failure to obtain sufficient financing to execute the Company’s business plan; competition; regulation and anticipated and unanticipated costs and delays, and other risks disclosed in the Company’s public disclosure record on file with the relevant securities regulatory authorities. Although the Company has attempted to identify important factors that could cause actual results or events to differ materially from those described in forward-looking statements, there may be other factors that cause results or events not to be as anticipated, estimated or intended. Readers should not place undue reliance on forward-looking statements. The forward-looking statements included in this news release are made as of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.
Forward-looking statements – Aphria Inc.
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS – APHRIA: Certain information in this news release constitutes forward-looking statements under applicable securities laws. Any statements that are contained in this news release that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements are often identified by terms such as “may”, “should”, “anticipate”, “expect”, “potential”, “believe”, “intend” or the negative of these terms and similar expressions. Forward-looking statements in this news release include, but are not limited to, statements with respect to internal expectations, estimated margins, expectations related to the completion of this project, its revenue and gross margin expectations, expectations for future growing capacity and costs, the completion of any capital project or expansions, any commentary related to the legalization of marijuana and the timing related thereto, expectations of Health Canada approvals and expectations with respect to future production costs. Forward-looking statements necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; marketing costs; loss of markets; future legislative and regulatory developments involving medical marijuana; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favourable terms; the medical marijuana industry in Canada generally, income tax and regulatory matters; the ability of Aphria to implement its business strategies; competition; crop failure; currency and interest rate fluctuations and other risks.
Readers are cautioned that the foregoing list is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking statements as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement.
Tetra Bio-Pharma Inc.
Edward Miller
Vice President, IR & Corporate Communications [email protected]
(343) 689-0714
Posted by AGORACOM-JC
at 11:07 AM on Tuesday, April 18th, 2017
Alibaba is venturing out of e-commerce and further into esport
Company’s sports subsidiary, Alisports, has joined with the Olympic Council of Asia to bring esports to the Asian Games.
Esports will appear at next year’s Games in Indonesia as a “demonstration,” Alibaba said, but will be a medal sport in China’s 2022 Games. The Asian Games are recognised by the International Olympic Committee, meaning in 2022 esports will be an official Olympic sport.
Esports is a growing market that is expected to garner 191 million global enthusiasts by the year’s end, according to research firm Newzoo. As of last April, the industry was worth over $450 million — a number expected to grow to $1 billion by 2019.
Posted by AGORACOM-JC
at 8:25 AM on Tuesday, April 18th, 2017
Windfall Lake Gold Camp area (the “Windfall East Property” and “Windfall West Property”, and collectively the “New Windfall Properties”) has been approved by the TSX Venture Exchange.
Durango closed the acquisition on April 11, 2017
Vancouver, BC / April 18, 2017 – Durango Resources Inc. (TSX.V-DGO) (Frankfurt-86A1) (OTC-ATOXF), (the “Company” or “Durango”) announces that further to its news release dated March 6, 2017, its recent acquisition of properties in the Windfall Lake Gold Camp area (the “Windfall East Property” and “Windfall West Property”, and collectively the “New Windfall Properties”) has been approved by the TSX Venture Exchange. Durango closed the acquisition on April 11, 2017.
The New Windfall Properties are comprised of approximately 2,700 hectares and adjoin the limit of Osisko Mining Inc.’s (TSX-OSK) property. The Windfall East Property is approximately five kilometres southeast of the Black Dog Au-Ag-Cu discovery. Osisko is currently drilling the extent of this new mineralization which appears as distinct subvertical zones dipping to the southeast and distributed along a NE-trending linear magnetic structure (Osisko’s Press release of January 18, 2017 and conceptual model on Osisko’s website).
The Windfall East Property runs along the southern perimeter of a projected large fault/lineament, a favorable environment for Archean lode gold deposit. Although the Windfall East Property is located outside the mapped Urban Barry greenstone belt, it remains prospective as many gold occurrences are found outside greenstone belts (eg. Cheechoo Project of Sirios Resources) and are rather driven by structural controls.
A limited amount of exploration work has been conducted over the Windfall East Property which totals an area of over 2,000 hectares. It is located within 1.5 km of the regional northeast-southwest faults extending from the Gladiator project of Bonterra Resources. A power line is crossing the central portion of the east claim block, and several lakes and rivers are present, which may facilitate access for future exploration work. Topography indicates that the area could be suitable for a till survey, as a first step to outline future targets.
The Windfall West Property is an additional block of approximately 675 hectares and is located to the west of Durango’s Trove property and adjoins Beaufield Resources Inc.’s (TSX.V-BFD) western perimeter and is accessible for exploration work via a main logging road from the town of Lebel-sur-Quevillon.
Marcy Kiesman CEO of Durango stated, “Durango is reviewing several exploration programs which could be initiated to advance the New Windfall Properties. Durango is confident in the prospective gold acquisitions in the Windfall area and looks forward to the exploration year ahead.”
The technical contents of this release were approved by Mrs. Isabelle Robillard, M.Sc., P.Geo., an associate of Inlandsis Consultants s.e.n.c who is a Qualified Person as defined by National Instrument 43-101.
Durango is a natural resources company engaged in the acquisition and exploration of mineral properties. The Company has a 100% interest in the Mayner’s Fortune and Smith Island limestone properties in northwest British Columbia, the Decouverte and Trove gold properties in the Abitibi Region of Quebec, and the NMX East lithium property near the Whabouchi mine and the Buckshot graphite property near the Miller Mine in Quebec, the Whitney Northwest property near the Lake Shore Gold and Goldcorp joint venture in Ontario.
For further information on Durango, please refer to its SEDAR profile at www.sedar.com.
This document may contain or refer to forward-looking information based on current expectations, including, but not limited to the exploration of the New Windfall Properties, the entering into of any transaction and/or financing with any third parties and the impact on the Company of these events. Forward-looking information is subject to significant risks and uncertainties, as actual results may differ materially from forecasted results. Forward-looking information is provided as of the date hereof and we assume no responsibility to update or revise them to reflect new events or circumstances. For a detailed list of risks and uncertainties relating to Durango, please refer to the Company’s prospectus filed on its SEDAR profile at www.sedar.com.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Posted by AGORACOM-JC
at 5:20 PM on Thursday, April 13th, 2017
The marijuana market could be (and possibly already is) bigger than the market for beer in Canada
Pot’s retail therapy
TORONTO — It’s a hot, sunny Thursday afternoon on the hard edge of Queen Street West, and the foot traffic at Eden, a pot dispensary, is brisk.
Retailers along this strip of trendy clothing stores, bars, restaurants, shoe shops, tattoo parlours, hairstylists, comic stores and coffee joints cater to the urban hip, and Eden is no different. lnside, iceberg-blue lights illuminate jewel-case cabinets with the product — glass vials of Hindu Kush, El Hefe, Organic Blue Dream — artfully displayed.
On the aquamarine-blue wall at the front are two white iPads, for customers who need quick access to the Internet to check product information.
The place is spotless, sharp. And the air is heavy with the unmistakeable sweet smell of cannabis.
The fridge at Eden Medicinal Society, a cannabis retailer in Toronto. (Tyler Anderson / National Post)
Behind the counter, two clerks, a man and a woman both in their 20s, both dressed like their customers, are filling orders, taking cash.
The average transaction, those in the business say, is $50. A pre-rolled joint is $12, but Alicia, the manager, says they won’t start selling a lot of those until the evening, when the university crowd and the kids from the suburbs come downtown.
The afternoonwalk-ins are largely cannabis users who rely on the flowers, ointments, teas, and oils to ease some chronic ailment, or they are creative types — writers, graphics artists, filmmakers — who find extra insight and energy through cannabinoid stimulation. They all have prescriptions from a licensed physician.
The product mix and retail approach at Eden’s downtown store is different than what you will find at the company’s newest outlet a few blocks north near Bayview and Eglinton. There are more seniors and aging baby boomers in that neighbourhood so the store opens earlier and closes earlier.
The Eden outlets are among the 100 or so pot dispensaries in Toronto, but there is easily demand, those in the industry say, for 1,000 such businesses.
They are owned and operated by a mix of campaigners and capitalists.
The campaigners have been working for years to legalize marijuana use. They believe in the huge potential for the drug to manage pain, ease anxiety, and help many to a more productive, happy, creative and healthy existence.
Tania Cyalume and Brandy Zurborg opened their storefront dispensary, Queens of Cannabis, on Bloor Street West just north of Little Italy in February.
Queens of Cannabis owners Tania Cyalume and Brandy Zurborg outside their shop in May 2016. (Maryam Shah / Postmedia Network)
“I guess when you believe in a product, you really believe in it because you’ve seen the way that it affects people,†said Cyalume.
The products Cyalume and Zurborg sell and their approach to retailing match their personal philosophies and lifestyles. Both are vegans, and the edible cannabis products they stock are vegan and pesticide-free.
Their crusade is about serving patients because they are patients themselves, and use cannabis products regularly to treat their own chronic pain and ailments.
“We’re patients and we believe in it. We also believe that patients have the first right to access before recreational. There is only so much supply, and there is a huge demand,†said Zurborg, who trained as a certified management accountant designation and was an auditor with the Canada Revenue Agency.
Their goal is not necessarily to get rich. They speak of one day being able to use the proceeds of their retail operation to help fund outreach, at hospices for example, where they can spread the word about the life-changing value of cannabis products.
Marina, who preferred her last name not be used, is a capitalist. She and her husband have had as many as seven dispensaries, some through a franchise model they were trying to build. When she got into the business a few years ago, she approached with a capitalist’s zeal and eye for profit.
The woman has agreed to talk about her industry at an upscale diner set among the forest of steel-and-glass condominium towers where Lake Ontario meets the Toronto suburb of Etobicoke. She arrived in a gleaming white SUV. Petite, direct and energetic, Marina makes no bones about the fact she got into the business to make a pile of cash.
– See more at: http://news.nationalpost.com/features/o-cannabis-retail-therapy#sthash.q9qC3FZy.dpuf
Posted by AGORACOM-JC
at 4:46 PM on Wednesday, April 12th, 2017
Announced today it has opened an office in Moncton, New Brunswick for its manufacturing and sales activities
New Brunswick becoming the hub for the Canadian Cannabis industry
OTTAWA, ONTARIO–(April 12, 2017) –Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (CSE:TBP)(CSE:TBP.CN)(OTCQB:GRPOF) announced today it has opened an office in Moncton, New Brunswick for its manufacturing and sales activities. New Brunswick is becoming the hub for the Canadian Cannabis industry.
Tetra is preparing to commercialize several retail products later this year with expected revenues to be generated for the corporation in the fourth quarter. Tetra has already initiated the process to manufacture the first products that act on the cannabinoid system that will be commercialized later this year for sale in Canada and the USA. The Company also intends on commercializing devices (e.g., pipes) for the consumption of medical marijuana in 2017. The Tetra office in Moncton will be responsible to oversee the timely production and launch of the products as well as adhering to the corporation’s budgets.
Tetra has initiated its Phase I clinical trial in March 2017 after manufacturing the PPP001 cannabis drug product at the Ford Pharma contract manufacturing facility in Moncton, New Brunswick. This contract facility developed the proprietary process and equipment required to produce PPP001 pellets and packaging operations. Tetra is also using the contract services of RPC, a New Brunswick provincial crown corporation, to perform its quality control studies to assure that PPP001 conforms to its drug product specifications and quality requirements of a prescription drug.
“We are pleased to announce the opening of a new office in New Brunswick which has become one of the leading provinces in Canada to support the cannabis industry,” said Andre Rancourt, CEO of Tetra Bio-Pharma Inc. “Tetra will manufacture our PPP001 prescription drug as well as additional scheduled products later this year. We are advancing our projects forward which are on time and on budget, a key priority for the Tetra team. We are now one-step closer towards our goal of commercialization in bringing our innovative cannabis based products to market.”
“We acted quickly to prepare for the development of this industry in New Brunswick,” said Stephen Lund, CEO of Opportunities NB. “The addition of Tetra Bio-Pharma to the province is welcomed news. We have the research, education and production facilities in place for companies to be successful in this rapidly growing industry.”
According to Dr. Guy Chamberland, CSO at Tetra Bio-Pharma Inc., “The use of the facility in Moncton allows Tetra to manufacture the PPP001 drug product for the clinical trial according to the corporation’s timelines and budget. The RPC research and technology organization provides Tetra with the high-level expertise required for assessing the quality aspects of PPP001 while keeping the costs associated with these activities within budget due to RPC not-for-profit status. I can report that the Phase 1 trial is advancing on schedule and according to the corporation’s plans we expect to complete the Phase Ia portion of the study by mid-May. The results of the Phase Ia will provide TBP with a strategic understanding of the commercial potential of marijuana products and allow the corporation to complete its Phase II and III trial plans.”
About Tetra Bio Pharma: Tetra Bio Pharma is a multi subsidiary publicly traded company (CSE:TBP)(CSE:TBP.CN)(OTCQX:GRPOF) engaged in the development of Bio Pharmaceuticals and Natural Health Products containing Cannabis and other medicinal plant based elements.
Tetra Bio Pharma is focused on combining the traditional methods of medicinal cannabis use with the supporting scientific validation and safety data required for inclusion into the existing bio pharma industry by regulators physicians and insurance companies. More information is available about the company at: www.tetrabiopharma.com.
The Canadian Securities Exchange (“CSE”) has not reviewed this news release and does not accept responsibility for its adequacy or accuracy.
Forward-looking statements Some statements in this release may contain forward-looking information. All statements, other than of historical fact, that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future (including, without limitation, statements regarding potential acquisitions and financings) are forward-looking statements. Forward-looking statements are generally identifiable by use of the words “may”, “will”, “should”, “continue”, “expect”, “anticipate”, “estimate”, “believe”, “intend”, “plan” or “project” or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Company’s ability to control or predict, that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements. Factors that could cause actual results or events to differ materially from current expectations include, among other things, without limitation, the inability of the Company, through its wholly-owned subsidiary, GrowPros MMP Inc., to obtain a licence for the production of medical marijuana; failure to obtain sufficient financing to execute the Company’s business plan; competition; regulation and anticipated and unanticipated costs and delays, and other risks disclosed in the Company’s public disclosure record on file with the relevant securities regulatory authorities. Although the Company has attempted to identify important factors that could cause actual results or events to differ materially from those described in forward-looking statements, there may be other factors that cause results or events not to be as anticipated, estimated or intended. Readers should not place undue reliance on forward-looking statements. The forward-looking statements included in this news release are made as of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.
Tetra Bio-Pharma Inc.
Edward Miller
Vice President, IR & Corporate Communications [email protected]
(343) 689-0714
Posted by AGORACOM-JC
at 10:35 AM on Wednesday, April 12th, 2017
Coal is the world’s largest source of energy for the production of electricity.
1 billion tons of coal used in global industrial steel production each year.
There are zero alternatives to coal in the industrial steel-making process.
Anthracite Coal
What Is It and Why This Is So Important?
Anthracite is officially classified as coal however it is not just another fuel, anthracite should not be confused with just ordinary bituminous coal.
Anthracite is the highest quality metallurgical coal available, clean burning, hard coal with the highest carbon content of any coal, very energy efficient and even burns smoke free.
This premium coal represents only 1% of world coal reserves.
The Cleanest Burning Solid Fossil Fuel
Anthracite is an almost pure form of carbon. It has a very high heat value, and very low levels of sulphur and other impurities. This makes it not only the most sought after home heating fuel but also a much sought after, high quality component for a number of industries.
The anthracite coal extracted from the AIM coal concessions in Peru have been tested by the world-wide highly regarded SGS labs and the findings indicate a very high fixed carbon, very low ash and sulpher content with a high calorific value.
AIM would be pleased to provide the analysis upon request.
Why Does the World Need Anthracite Coal?
As a result of its attributes, anthracite coal trades at prices substantially higher than thermal coal and has a lower environmental impact. High quality anthracite is increasingly sought for by the steel industry, always under pressure to reduce costs and improve margins.
Metallurgical coal together with iron ore is the principal raw materials used to make steel. As such, it supports an improved quality of life for all of us through its use in the construction of homes and hospitals, and in the production of everything from mass transportation vehicles to wind turbines.
Due to its high carbon content and low volatiles, anthracite is more reactive and efficient with respect to energy released than the lower–ranked coals and consequently has a lower environmental impact due to the lower greenhouse gas emissions.
The industry most commonly associated with anthracite is the steel industry.
Within the steelmaking industry, anthracite is used in three processes
Pulverized coal injection
Basic Oxygen Steel
Electric Arc Furnaces
Present Activities
Assets encompass 1,000 hectares of mining concession property consisting of three sites of 600, 200 and 200 hectares respectively.
Percana SA initially acquired these properties based on indications of the presence of high grade anthracite coal. Illegal artisan miners are currently operating multiple one-entry mines on the property, which further indicates the presence and mine-ability of these deposits.
To verify the geology and quality of the coal, Percana SA commissioned local geologists to compile a technical report on the 1,000 hectares. Although the report yielded optimistic estimates of resources, reserves and economics, it does not meet public reporting standards.
LOCATION
located in Huaranchal, which is one of ten districts in the province of Otuzco.
Two-hour drive from Trujillo (the second largest city in Peru), and an equal distance to the city of Otuzco.
Also strategically located 200km from Salaverry, which features a port that can service ships with capacities of up to 35,000 tons. The Port of Salaverry provides direct access to the Pacific Ocean.
INFRASTRUCTURE
Water
A river adjacent to the property provides access to water for mining operations. However, most of the coal on the property may be extracted with minimal or no coal washing.
Power
Power lines cut through the property, although Aim is yet to ascertain the capacity of these lines. The company expects to use diesel powered equipment for most of its mining activities.
Roads
The first half of the road from the property to Otuzco is along steep mountainsides and can support 25-ton trucks. The next half of the road to Otuzco is better maintained and can also support 25-ton trucks. The road from Otuzco to the Port of Salaverry is well constructed, paved, and has bridges that can support up to 50-ton loads. This will facilitate smooth hauling of coal to the port.
Besides accessibility to water, transportation and electricity, there are also small villages on the property with ample accommodations and restaurants to service exploration crews and other travelers.
Market Potential
Highly desirable resource with a variety of uses. I
Primarily used in the manufacturing of steel, the production of cement, and the generation of electricity.
70% of the steel produced globally relies on coal (World Coal Association, 2013); 200kg of coal is required to produce one ton of cement (Van Oss, 2012); and 41% of global electricity production relies on coal (Clemente, 2012).
Highest ranking coal because it is older and harder, contains more carbon, has lower moisture content, and burns hotter than any other type of coal. Comprising only 1% of global reserves, anthracite is also the cleanest burning fossil fuel on the planet (Cornerstone, 2013).
Once the joint venture with Prina Energy Aim intends to sell its output to international customers through the joint venture corporation concentrating the marketing efforts in India.
Unavailability of Anthracite Coal in India creates a huge potential for coal as a fuel for Indian Steel industry, which is growing on progressive and steady pace.
Huge scope for growth is offered by India’s comparatively low per capita steel consumption and the expected rise in consumption due to increased infrastructure construction and the thriving automobile and railways sectors.
Competitive Advantage
Aim has a variety of advantages. The company has a team of technical experts on ground in Peru, and has also recruited advisors and directors who bring complementary skills to the venture. In terms of infrastructure, power lines run through Aim’s property, while a river runs adjacent to the site. The road network from the site to Otuzco can support 25-ton trucks. From Otuzco to Salaverry, the road is paved and well maintained, and can support up to 50-ton trucks. There are also accommodation facilities close to the property that can cater to Aim employees and contractors. Other advantages include competitive labour wages in Peru, and competitive storage and stevedoring costs at the port together with the ability to extract deposits with minimal or no coal washing.
Posted by AGORACOM-JC
at 9:50 AM on Wednesday, April 12th, 2017
Management confirms its limestone is suitable for fertilizer use
Limestone is extremely beneficial for the agricultural industry including its use as a soil conditioner
Vancouver, BC / April 12, 2017 – Durango Resources Inc. (TSX.V-DGO) (OTC-ATOXF), (the “Company” or “Durango”) announces that further to the news of April 5, 2017 management confirms its limestone is suitable for fertilizer use.
Upon review, it was determined that Durango’s limestone is exempt from the registration process of the Canadian Food Inspection Agency (CFIA). The limestone is still subject to regulations and required to meet all the standards and requirements set forth in the Fertilizers Act and Regulations. Fertilizer and supplement products are regulated under the authority of the Fertilizers Act, which is administered by the CFIA.
Limestone is extremely beneficial for the agricultural industry including its use as a soil conditioner. The limestone is activated when it meets with water and dissolves into the soil, which lowers the acidity and raises the pH, which is essential for crop yields. The lime also adds desirable nutrients to the soils such as calcium, magnesium and phosphorus, which can improve soil structure, increase rates of air and water filtration, improve plant cell wall formation, and help regulate the nutrient uptake through the roots of the plant. Hydroponic-type systems are more prone to incur a calcium deficiency and require the use of limestone.
Marcy Kiesman, CEO of Durango stated, “Durango is fortunate to have highly favourable grades of limestone on the Mayner’s Fortune property. This creates additional opportunities for potential end-users which Durango will now actively investigate commercial-use mediums for its limestone due to the recent CFIA discussions.”
About Mayner’s Fortune
The Mayner’s Fortune property is located 7.5 kilometres southwest of Terrace, B.C., along the CN rail route between Terrace and Kitimat and hosts six historically mapped subparallel limestone units. Durango completed two exploration visits on the Mayner’s Fortune project in the late fall of 2016, which included sampling to test limestone quality and mapping substantiate historic reports. Assays of results of February 8, 2017 and December 14, 2016 achieved CaCO3* (calcium carbonate) (56.00 per cent CaCO (calcium oxide)).
*Theoretical value of CaCO3 is calculated based on the assay value of CaO at 1.78476 per cent and is used to estimate limestone (CaCO3) composition. This calculation assumes all CaO analyzed is present at CaCO3.
Durango is a natural resources company engaged in the acquisition and exploration of mineral properties. The Company has a 100% interest in the Mayner’s Fortune and Smith Island limestone properties in northwest British Columbia, the Decouverte and Trove gold properties in the Abitibi Region of Quebec, and the NMX East lithium property near the Whabouchi mine and the Buckshot graphite property near the Miller Mine in Quebec, the Whitney Northwest property near the Lake Shore Gold and Goldcorp joint venture in Ontario.
For further information on Durango, please refer to its SEDAR profile at www.sedar.com.
This document may contain or refer to forward-looking information based on current expectations, including, but not limited to the acquisition of additional ground, the entering into of any transaction with any third parties, exploration results on the Mayner’s Fortune Property and the impact on the Company of these events. Forward-looking information is subject to significant risks and uncertainties, as actual results may differ materially from forecasted results. Forward-looking information is provided as of the date hereof and we assume no responsibility to update or revise them to reflect new events or circumstances. For a detailed list of risks and uncertainties relating to Durango, please refer to the Company’s prospectus filed on its SEDAR profile at www.sedar.com.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Posted by AGORACOM-JC
at 4:23 PM on Tuesday, April 11th, 2017
Why Monarques Gold?
Flagship Croinor Gold Mine Has Great Potential To Become A Producer
Company Is Well Financed, Including $9 Million In Credits From Quebec Government
Hole CR-17-532 intersected 6.96 g/t Au over 15 metres (Read Release)
Including 17.1 g/t Au over 5.9 metres
Recently acquired 750 ton-per-day Beacon mill
Major Shareholders include: Rob McEwen and Nemaska Lithium
Croinor Gold Property
Flagship project at the prefeasibility stage
100% interest in the Croinor Gold property, a gold mine project that is currently at the prefeasibility stage
Property consists of one mining lease and two non-contiguous blocks of claims for a total of 335 claims over a 151 km² area. A 1.5% NSR is applicable on the mining lease and only 44 claims.
Drilling program will test a diorite-hosted gold-bearing zone that returned grades of up to 38.7 g/t Au over 3.8 metres in historical drilling (see release)
The Simkar Gold property is the result of a merger of the Simkar and Texsol properties. The transaction was announced by way of press release on June 26, 2014.
Regcourt Gold Property – Val d’Or
100% interest in the Regcourt Gold property
Property is located at the eastern end of the Val-d’Or gold mining camp, some 30 km east of Val-d’Or, and is easily accessible via Route 117.
Consists of 94 claims covering an area of 38 km2 near the centre of the western border of Vauquelin Township
Property is subject to a 1.5% and 2.5 % NSR.
12 Month Stock Chart
Posted in AGORACOM Client Feature, Monarques Gold | Comments Off on FEATURE: Monarques Gold (TSX-V: MQR) Flagship Croinor Gold Mine Has Great Potential To Become A Producer $MQR.ca
Assets encompass 1,000 hectares of mining concession property consisting of three sites of 600, 200 and 200 hectares respectively.
